Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 30, 2004
Permeability modulation of human intestinal Caco-2 cell monolayers by interferonsHiroko Kawaguchi, Yukiko Akazawa, Yoshihiko Watanabe, et al.The Journal of Pharmacology and Experimental Therapeutics|October 22, 2003
Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouseHiroko Kawaguchi, Yumi Matsui, Yoshihiko Watanabe, et al.Lab on a Chip|July 18, 2012
Micro fluorescent analysis system integrating GaN-light-emitting-diode on a silicon platformHiroto Nakazato, Hiroko Kawaguchi, Akio Iwabuchi, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 12, 2023
Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liverShun Hayashi, Hiroko Kawaguchi, Takao Watanabe, et al.Drug Metabolism and Pharmacokinetics|December 13, 2021
Investigation of the role and quantitative impact of breast cancer resistance protein on drug distribution into brain and CSF in ratsYuki Katagiri, Hiroko Kawaguchi, Koji Umemura, et al.Journal of Pharmaceutical Sciences|September 13, 2002
Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytesYukiko Akazawa, Hiroko Kawaguchi, Maki Funahashi, et al.Neurochemistry International|December 30, 2008
A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytesShinsuke Nakagawa, Mária A Deli, Hiroko Kawaguchi, et al.Drug Metabolism and Pharmacokinetics|July 15, 2020
Prediction methods of drug-drug interactions of non-oral CYP3A4 substrates based on clinical interaction data after oral administrations - Validation with midazolam, alfentanil, and verapamil after intravenous administration and prediction for blonanserin transdermal patchYoshiko Tomita, Masahiro Yahata, Masayo Hashimoto, et al.Oncotarget|March 24, 2018
Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinityRyutaro Asano, Keisuke Nagai, Koki Makabe, et al.Nature Communications|April 25, 2013
Max is a repressor of germ cell-related gene expression in mouse embryonic stem cellsIkuma Maeda, Daiji Okamura, Yuko Tokitake, et al.Pageof 2